欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0231/002
药品名称Co-Angiosan 160 mg/ 12,5 mg Filmtabletten
活性成分
    • hydrochlorothiazide 13.0 mg
    • valsartan 160.0 mg
剂型Film-coated tablet
上市许可持有人Novartis Pharma GmbH Roonstr. 25 D-90429 Nuernberg
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Austria (AT)
      Co-Angiosan forte 160 mg/12,5 mg-Filmtabletten
    • Greece (GR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Angiosan Comp
许可日期2003/08/28
最近更新日期2008/04/05
药物ATC编码
    • C CARDIOVASCULAR SYSTEM
    • C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
    • C09A ACE INHIBITORS, PLAIN
    • C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
    • C09DA Angiotensin II receptor blockers (ARBs) and diuretics
    • C09DA03 valsartan and diuretics
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed Combination Article 4.8b
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase